Terms: = Lymphoma AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Prognosis
2 results:
1. Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.
Demir AB; Aktas S; Altun Z; Ercetin P; Aktas TC; Olgun N
Folia Biol (Praha); 2021; 67(1):1-9. PubMed ID: 34273261
[TBL] [Abstract] [Full Text] [Related]
2. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract] [Full Text] [Related]
